Would You Be Glad To Own Synopsys At A Discount While AI Tests Its Software?

Synopsys (SNPS) trades about 26% below its 52-week high after falling about 34% over the past year. You can be paid now to agree to buy it well below today’s price, and you keep that payment either way. The catch is that you must want the business. One analyst says investors constantly ask whether AI could disrupt the kind of software Synopsys sells, and that a school of thought asks whether AI could design chips end to end without it.

10% annualized yield at a 30% margin of safety, by selling put options.

• Sell a put option on SNPS expiring 9/17/2027, with a strike price of $280.
• Collect roughly $1,840 in premium per contract (each contract covers 100 shares).
• That works out to about 6.4% annualized on the $28,000 of cash you set aside to secure the trade.
• Park that cash in Treasury bills or a Treasury money-market fund yielding roughly 4.0%, and your total yield climbs to about 10.4%.
• And if SNPS falls below $280, you buy it at $280, an effective entry near $261.60 a share after the premium, about a 34% discount to today’s $397.17.

Win Or Wait, You Still Pocket The Premium

If SNPS stays above $280 through 9/17/2027, the put expires worthless and you simply keep the full $1,840 premium. That is about 6.4% annualized on the $28,000 you set aside over 372 days, while that same collateral keeps earning the ~4.0% T-bill yield on top, for the ~10.4% total above. You never buy the stock and keep the income, free to do it again.

If SNPS closes below $280, you are assigned and buy 100 shares at $280. The $1,840 premium you already pocketed lowers your effective cost to about $261.60 a share, roughly a 34% discount to today’s price, though if the stock has fallen further by then you would be holding a paper loss.

Suppose the shares close below the strike and you are assigned. What you own then matters far more than the premium.

What Would You Own At The Strike?

Synopsys sells the software chipmakers use to design and verify their parts. Fiscal Q3 2026 revenue was $2.477 billion, up about 42% including the Ansys simulation business it bought a year ago. EDA revenue, which includes record hardware-assisted verification sales, grew 8.5% against a year-earlier quarter that grew 16%.

Design IP, the interface and memory designs Synopsys licenses, returned to growth, up about 11% year on year. Multiphysics Fusion, the first solution combining Synopsys and Ansys technology, has been validated by customers including NVIDIA and Samsung Foundry. Management expects it to start adding to EDA growth in 2027.

If AI can design chips without commercial tools, growth like this is worth far less. Management argues the reverse: early feedback shows AI agents running its EDA tools at a much higher rate, so customers need more licenses. That is the bet a put seller is really paid to take.

Synopsys also carries about $10 billion of debt against $3.6 billion of cash and short-term investments at the end of fiscal Q3 2026. That debt load already reflects term loans repaid early, and Synopsys raised its fiscal 2026 free cash flow outlook to about $2.6 billion, though operating margin is 11.0% over the trailing twelve months against a 17.6% three-year average.

Which Number Will Show Whether AI Helps Synopsys?

EDA revenue growth. Agents that replace design software would slow it, and agents that run more of that software would speed it up. Management expects organic EDA growth in double digits in fiscal Q4 2026 and for fiscal 2026 as a whole. The CEO calls fiscal Q3’s 8.5% EDA growth organic.

One analyst has asked whether software is keeping pace with hardware, and the CEO says management is very happy with the software side. How Synopsys gets paid matters too: it is working with customers on subscription plus consumption pricing for agents, and on licensing plus royalties for customized IP, a model it calls Factory 2.

Management plans to share more on both at its September 30 Investor Day. The fiscal Q4 2026 report is the test. If EDA growth hits double digits with software pulling its weight, management’s case gains ground. If it misses, the company’s central question has grown harder, and you still carry the obligation to buy at $280 when the put expires on 9/17/2027.

So Should You Risk Owning Synopsys For The Premium?

Only if you would hold Synopsys calmly through a further fall while the AI question plays out. People get this wrong because the payment arrives first and the shares arrive only after bad news, so the pleasant half makes the decision.

Implied volatility on Synopsys options sits near the middle of its past-year range, so this premium is not unusually rich by the stock’s own standard. Compare what the same trade pays elsewhere on the cash-secured put yield screen.

Where Does A Put On Synopsys Fit In Your Portfolio?

The trade ties your cash to one company and one argument about AI, so it fits as a small position, not a core holding. The Trefis High Quality Portfolio spreads single-stock risk across quality businesses with sustainable growth and strong cash generation. That portfolio has a track record of outpacing the three major indices.